{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:28:03Z","timestamp":1793946483034,"version":"4.8.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002648","name":"Catholic University of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.critrevonc.2026.105508","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:10:33Z","timestamp":1785510633000},"page":"105508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SMG1 in hepatocellular carcinoma: A context-dependent tumor suppressor and a targetable node for NMD-directed immunotherapy"],"prefix":"10.1016","volume":"226","author":[{"given":"Soon Woo","family":"Nam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105508_bib1","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100070","article-title":"Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","volume":"1","author":"Abou-Alfa","year":"2022","journal-title":"NEJM Evid."},{"key":"10.1016\/j.critrevonc.2026.105508_bib2","article-title":"SMG6-dependent nonsense-mediated decay maintains dsRNA homeostasis and suppresses immunogenic transcripts in a hepatocellular carcinoma model","author":"Arpa","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.critrevonc.2026.105508_bib3","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3390\/pharmaceutics15082130","article-title":"Targeting EGFR\/PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma","volume":"15","author":"Bang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.critrevonc.2026.105508_bib4","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2026.105508_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.molcel.2004.05.005","article-title":"The mRNA surveillance protein hSMG-1 functions in genotoxic stress response pathways in mammalian cells","volume":"14","author":"Brumbaugh","year":"2004","journal-title":"Mol. Cell."},{"key":"10.1016\/j.critrevonc.2026.105508_bib6","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","author":"Cancer Genome Atlas Research Network","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105508_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105508_bib8","doi-asserted-by":"crossref","first-page":"16752","DOI":"10.1074\/jbc.M109.014316","article-title":"Kinome siRNA screen identifies SMG-1 as a negative regulator of hypoxia-inducible factor-1\u03b1 in hypoxia","volume":"284","author":"Chen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2026.105508_bib9","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.95952","article-title":"Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape","volume":"13","author":"Cook","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.critrevonc.2026.105508_bib10","doi-asserted-by":"crossref","first-page":"22709","DOI":"10.1074\/jbc.C100144200","article-title":"Cloning of a novel phosphatidylinositol kinase-related kinase: characterization of the human SMG-1 RNA surveillance protein","volume":"276","author":"Denning","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2026.105508_bib11","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetics in cancer","volume":"358","author":"Esteller","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105508_bib12","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105508_bib13","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.4161\/cc.26660","article-title":"SMG-1 suppresses CDK2 and tumor growth by regulating both the p53 and Cdc25A signaling pathways","volume":"12","author":"Gubanova","year":"2013","journal-title":"Cell. Cycle"},{"key":"10.1016\/j.critrevonc.2026.105508_bib14","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3892\/or.2014.3125","article-title":"Expression and significance of the novel tumor-suppressor gene SMG-1 in hepatocellular carcinoma","volume":"31","author":"Han","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.critrevonc.2026.105508_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.701454","article-title":"SMG9 serves as an oncogene to promote tumor progression via EMT and Wnt\/\u03b2-catenin signaling pathway in hepatocellular carcinoma","volume":"12","author":"Jin","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105508_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1101\/gad.1389006","article-title":"Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay","volume":"20","author":"Kashima","year":"2006","journal-title":"Genes. Dev."},{"key":"10.1016\/j.critrevonc.2026.105508_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1089\/nat.2016.0635","article-title":"Antisense oligonucleotides modulating activation of a nonsense-mediated RNA decay switch exon in the ATM gene","volume":"26","author":"Kralovicova","year":"2016","journal-title":"Nucleic Acid. Ther."},{"key":"10.1016\/j.critrevonc.2026.105508_bib18","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72353","article-title":"Cryo-EM reconstructions of inhibitor-bound SMG1 kinase reveal an autoinhibitory state dependent on SMG8","volume":"10","author":"Langer","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.critrevonc.2026.105508_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57127","article-title":"Structure of substrate-bound SMG1-8-9 kinase complex reveals molecular basis for phosphorylation specificity","volume":"9","author":"Langer","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.critrevonc.2026.105508_bib20","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/s41588-019-0517-5","article-title":"The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy","volume":"51","author":"Lindeboom","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2026.105508_bib21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105508_bib22","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.critrevonc.2026.105508_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12943-022-01679-6","article-title":"IL-6\/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction","volume":"21","author":"Meraviglia-Crivelli","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105508_bib24","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3892\/ijo.2014.2540","article-title":"Genetic screen identifies suppressor of morphogenesis in genitalia-1 (SMG-1) as a modulator of sorafenib resistance in hepatocellular carcinoma cell lines","volume":"45","author":"Nam","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105508_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105508_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12964-025-02503-6","article-title":"Nonsense-mediated mRNA decay: a key regulatory system engaged in cancer","volume":"23","author":"Pan","year":"2025","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.critrevonc.2026.105508_bib27","doi-asserted-by":"crossref","first-page":"E285","DOI":"10.1073\/pnas.1215696110","article-title":"Smg1 haploinsufficiency predisposes to tumor formation and inflammation","volume":"110","author":"Roberts","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2026.105508_bib28","doi-asserted-by":"crossref","DOI":"10.48101\/ujms.v129.10719","article-title":"Therapeutic targeting of TP53 nonsense mutations in cancer","volume":"129","author":"Strandgren","year":"2024","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.critrevonc.2026.105508_bib29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.tig.2020.11.002","article-title":"To NMD or not to NMD: nonsense-mediated mRNA decay in cancer and other genetic diseases","volume":"37","author":"Supek","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.critrevonc.2026.105508_bib30","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.immuni.2026.02.005","article-title":"Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidome","volume":"59","author":"Vendramin","year":"2026","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2026.105508_bib31","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1038\/onc.2010.236","article-title":"The role of signaling pathways in the development and treatment of hepatocellular carcinoma","volume":"29","author":"Whittaker","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105508_bib32","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1470-2045(18)30351-6","article-title":"Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial","volume":"19","author":"Zhu","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105508_bib33","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41422-019-0255-3","article-title":"Cryo-EM structure of SMG1-SMG8-SMG9 complex","volume":"29","author":"Zhu","year":"2019","journal-title":"Cell. Res."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:36:13Z","timestamp":1793943373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826003951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"alternative-id":["S1040842826003951"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105508","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SMG1 in hepatocellular carcinoma: A context-dependent tumor suppressor and a targetable node for NMD-directed immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105508"}}